BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cancer Epigenetics Society - ECPv5.3.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cancer Epigenetics Society
X-ORIGINAL-URL:https://ces.b2sg.org
X-WR-CALDESC:Events for Cancer Epigenetics Society
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181105
DTEND;VALUE=DATE:20181108
DTSTAMP:20260729T200804
CREATED:20180515T104441Z
LAST-MODIFIED:20180515T105251Z
UID:20079-1541376000-1541635199@ces.b2sg.org
SUMMARY:Making it Personal: Cancer Precision Medicine
DESCRIPTION:After two highly-rated previous editions\, the 3rd EACR conference on the topic of personalised medicine will update you on the latest challenges and advances in targeted and immunological cancer therapies. It will cover a broad spectrum of basic\, translational and clinical research\, all related to currently pressing questions relevant across cancer types. \nThe multidisciplinary programme will encompass developments in diagnosis and early detection\, including novel bioinformatic approaches. New immuno-oncology treatments will also be presented\, emphasising the role of the tumour microenvironment and showcasing systems immunology. The emergence and role of drug-tolerant tumour fractions will be discussed in the context of drug resistance. And\, reflecting one of the major needs\, there will be a focus on rational design of combinatorial therapies and on how advances emerging from the laboratory are clinically implemented. \nThe programme includes 17 plenary lectures\, dedicated poster sessions and interactive elements. The small size of the conference makes it an excellent forum to share new data\, and to network with colleagues and speakers. \nWho should attend?\nWe welcome all basic\, translational and clinical scientists (including postdocs and trainees)\, who are interested in tackling pressing cancer-relevant questions\, and who want to hear the latest developments in therapies targeting cancer and immune cells. We also invite industry scientists who are interested in targets for novel therapies. This is an excellent forum for informal networking and meeting potential collaborators. \nTopics to be covered\n\nDiagnosis\nEarly detection\nTumour microenvironment\nImmuno-oncology\nTargeted tumour therapy\nDrug tolerance\nComputational discovery of cancer vulnerabilities\nTherapy resistance\nClonal evolution\nRational treatment combinations\nClinical implementation of exceptional responder data\n\n  \nKey dates\nBursary application deadline:\n03 September 2018 \nAbstract submission deadline:\n03 September 2018 \nRegistration deadline:\n01 October 2018
URL:https://ces.b2sg.org/event/eacr-5nov18/
LOCATION:Centro Congressi Giovanni XXIII\, Viale Papa Giovanni XXIII\, Bergamo\, 24121\, Italy
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2018/05/EACR-new-logo-jpeg-e1526380502516.jpg
END:VEVENT
END:VCALENDAR